JULIET: CAR T cells go the distance in r/r DLBCL

SAN DIEGO – Median overall survival among patients with complete responses to CAR-T cell therapy in the JULIET trial has not been reached.

Conference Coverage

VIDEO: Practice changers out of ASH 2017

ATLANTA – Dr. Robert Brodsky shares his takeaways on the key practice changing data presented in the ASH 2017 late breakers.

Conference Coverage

AUDIO: Immunotherapy’s role in NHL

Dr. Stephen Ansell outlines the challenges in using immunotherapy effectively in non-Hodgkin lymphoma and future directions.